Max Chan
Director of Finance/CFO bij FORESEE PHARMACEUTICALS CO., LTD.
Profiel
Max Chan is currently a Member-Supervisory Board at Wisepal Technologies, Inc., Harvest Investments Ltd., Himax Imaging Ltd., Himax Media Solutions, Inc., Himax Taiwan, Inc., Himax Semiconductor Ltd., Eden Biologics, Inc., and Foresee Pharmaceuticals Co., Ltd.
He previously worked as a Manager-Intel Capital Treasury at Intel Corp., Manager-Overseas Direct Investment Department at CDIB Capital Group, Chief Financial Officer at Himax Technologies, Inc., CFO, Head-Finance & Administration at TaiGen Biotechnology Co., Ltd., Senior Associate at Credit Suisse First Boston Asia International (Cayman) Ltd., and Deputy General Manager & Head-Finance at OBI Pharma, Inc. Mr. Chan received a graduate degree from the University of Illinois and undergraduate and MBA degrees from National Taiwan University.
Actieve functies van Max Chan
| Bedrijven | Functie | Begin |
|---|---|---|
| JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20-10-2015 |
| FORESEE PHARMACEUTICALS CO., LTD. | Director of Finance/CFO | 07-10-2019 |
| Himax Taiwan, Inc. | Director of Finance/CFO | 08-03-2010 |
| Himax Media Solutions, Inc. | Director/Board Member | 08-03-2010 |
| Himax Imaging Ltd. | Director/Board Member | 08-03-2010 |
Wisepal Technologies, Inc.
 Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The private company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Director/Board Member | 08-03-2010 |
| Harvest Investments Ltd. | Director/Board Member | 09-12-2010 |
| Himax Semiconductor Ltd. | Director/Board Member | 09-12-2010 |
Eerdere bekende functies van Max Chan
| Bedrijven | Functie | Einde |
|---|---|---|
| OBI PHARMA, INC. | Director of Finance/CFO | 01-01-2019 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Max Chan
| University of Illinois | Graduate Degree |
| National Taiwan University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| INTEL CORPORATION | Electronic Technology |
| HIMAX TECHNOLOGIES, INC. | Electronic Technology |
| OBI PHARMA, INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Bedrijven in privébezit | 10 |
|---|---|
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The private company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
| Harvest Investments Ltd. | |
| Himax Imaging Ltd. | |
| Himax Media Solutions, Inc. | |
| Himax Taiwan, Inc. | |
| Himax Semiconductor Ltd. | |
| Credit Suisse First Boston Asia International (Cayman) Ltd. | |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
